NDC properties for NDC 9 0074-0817
NDC item 00074081702
| NDC 9 | 0074-0817 |
|---|---|
| NDC 10 | 0074-0817-02 |
| NDC Item | 00074081702 |
| packaging | 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA125057 |
| FDA SPL set id | 770190 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2017-04-28 |
| Marketing status | ACTIVE |
NDC item 83457081601
| NDC 9 | 83457-816 |
|---|---|
| NDC 10 | 83457-816-01 |
| NDC Item | 83457081601 |
| packaging | 0.1 mL in 1 SYRINGE |
| packaging | 1 in 1 TRAY |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 83457081702
| NDC 9 | 83457-817 |
|---|---|
| NDC 10 | 83457-817-02 |
| NDC Item | 83457081702 |
| packaging | 2 KIT in 1 CARTON (83457-817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-816-01) / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
| BLA | BLA125057 |
| FDA SPL set id | 771346 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-02-14 |
| Marketing status | ACTIVE |